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Abstract
Background: A better understanding of potentially modifiable predictors of in-hospital mortality and re-admission to 
the hospital following discharge may help to improve management of community-acquired pneumonia in older 
adults. We aimed to assess the associations of potentially modifiable factors with mortality and re-hospitalization in 
older adults hospitalized with community-acquired pneumonia.
Methods: A prospective cohort study was conducted from July 2003 to April 2005 in two Canadian cities. Patients 
aged 65 years or older hospitalized for community-acquired pneumonia were followed up for up to 30 days from initial 
hospitalization for mortality and these patients who were discharged alive within 30 days of initial hospitalization were 
followed up to 90 days of initial hospitalization for re-hospitalization. Separate logistic regression analyses were 
performed identify the predictors of mortality and re-hospitalization.
Results: Of 717 enrolled patients hospitalized for community-acquired pneumonia, 49 (6.8%) died within 30 days of 
hospital admission. Among these patients, 526 were discharged alive within 30 days of hospitalization of whom 58 
(11.2%) were re-hospitalized within 90 days of initial hospitalization. History of hip fracture (odds ratio (OR) = 4.00, 95% 
confidence interval (CI) = (1.46, 10.96), P = .007), chronic obstructive pulmonary disease (OR = 2.31, 95% CI = (1.18, 4.50), 
P = .014), cerebrovascular disease (OR = 2.11, 95% CI = (1.03, 4.31), P = .040) were associated with mortality. Male sex 
(OR = 2.35, 95% CI = (1.13, 4.85), P = .022) was associated with re-hospitalization while vitamin E supplementation was 
protective (OR = 0.37 (0.16, 0.90), P = .028). Lower socioeconomic status, prior influenza and pneumococcal 
vaccinations, appropriate antibiotic prescription upon admission, and lower nutrition risk were not significantly 
associated with mortality or re-hospitalization.
Conclusion: Chronic comorbidities appear to be the most important predictors of death and re-hospitalization in 
older adults hospitalized with community-acquired pneumonia while vitamin E supplementation was protective.
Background
Community-acquired pneumonia (CAP) is one of the
leading causes of mortality in older adults aged 65 years
or more [1-6]. Re-hospitalization due to pneumonia after
premature hospital discharge or due to new or worsening
of co-existing medical complications is associated with
extra use of medical resources, increased costs and
deaths [7].
Demographic factors such as age and comorbidities
such as chronic lung diseases (COPD) may not fully
explain mortality and re-hospitalization associated with
CAP in the elderly. A better understanding of potentially
modifiable predictors of in-hospital mortality and re-
admission to the hospital following discharge may help to
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improve management of pneumonia in this vulnerable
population. However, conflicting evidence exists regard-
ing the role of modifiable factors, such as influenza and
pneumococcal vaccines [8-10] and guideline-based anti-
microbial use [11-14]. Malnutrition has been found to be
associated with mortality [15,16] and re-admission [15] of
patients discharged alive within 30 days of initial hospi-
talization. Poor functional status has also been associated
with 30-day in-hospital mortality [15,17]. However, this
finding was not seen in another study [18]. Problems with
these studies include small sample sizes [14-18], retro-
spective designs based on administrative records [11,12],
and/or failure to use rigorous definition of CAP [18].
Accurate identification of pneumonia cases could be a
problem especially in retrospective studies using admin-
istrative data (where up to 40% of all cases of pneumonia
diagnosed by ER physicians were not confirmed as so by
radiologists) [19].
In this prospective cohort study where all pneumonia
cases were confirmed by radiologists, we sought to iden-
tify the predictors of 30-day mortality in older adults with
CAP and hospital re-admission within 90 days among
these patients who were discharged alive to home, nurs-
ing home or another hospital within 30 days of their ini-
tial hospitalization. We specifically sought to assess the
associations of potentially modifiable risk factors includ-
ing immunization history, empiric antimicrobial use, as
well as socioeconomic, nutritional and functional sta-
tuses.
Methods
Study Participants
In this prospective cohort study, patients aged 65 years
and older who were hospitalized for CAP in 10 hospitals
in Hamilton, Ontario and Edmonton, Alberta, Canada
were enrolled from 2003 to 2005. There are four emer-
gency departments (EDs) in Hamilton, serving a catch-
ment area of approximately 2.2 million people, and six
EDs in Edmonton, serving a catchment area of about 1
million people. Eligible participants had to live in one of
these two catchment area communities and have at least
two of the following signs and symptoms: temperature
>38°C, productive cough, chest pain, shortness of breath,
or crackles on auscultation. They also had to have a new
opacity on a chest radiograph that was interpreted by a
radiologist as being compatible with pneumonia. Exclu-
sion criteria were residing in a nursing home and infec-
tion at another site in addition to CAP.
The study was approved by the Hamilton Health Sci-
ences Research Ethics Board, St. Joseph's Hospital
Research Ethics Board, and the University of Alberta
Research Ethics Board. Informed consent was obtained
from all participants.
Data
Trained interviewers collected health data of the initial
hospital admission after the patients were identified in
EDs and enrolled in the study. Demographic, comorbid-
ity, lifestyle and other health related data were collected
from patients by personal interviews using structured
questionnaires and additional complementary informa-
tion was extracted from patients' medical charts. The
demographic variables included age, sex, height and
weight to calculate body mass index, marital status
(whether married and living with spouse or not), and liv-
ing arrangement (alone or in a family). Comorbidity vari-
ables included asthma, cancer, chronic obstructive
pulmonary disease (COPD), congestive heart failure,
cerebrovascular disease, liver disease, renal disease, and
diabetes mellitus. In addition, data was collected on men-
tal confusion, vital signs, empiric antibiotics used upon
admission, medication history including use of vitamins,
minerals and immunosuppression drugs, and influenza
and pneumococcal immunizations prior to hospital
admission.
Level of education was used as a proxy for socioeco-
nomic status since older adults may not have income
from active employment. Patients were considered hav-
ing low socioeconomic status if they had less than high
school education. Life-style variables included smoking
(whether or not a patient smoked 100 or more cigarettes
in lifetime), household smoking (whether or not any
member in the patient's family smoked), amount of alco-
hol consumption (mean grams of alcohol per month in
the last 12 months). Nutritional status was assessed using
a 15-item adaptation of the Nutrition Screening Initiative
Level I 10 statement [20] and the Mini-Nutritional
Assessment [21,22], with scores ranging from 0 (high
nutritional risk) to 60 (no nutritional risk). Patient's func-
tional status was assessed using 10-item modified Barthel
Index [23], with scores ranging from 0 (full dependence)
to 20 (complete independence). The data were highly
skewed with most participants having high scores; we
dichotomized the Barthel Index score into 17 or less for
lower functional status (some dependency) versus 18 to
20 for higher functional status (slight to no dependency).
Severity of pneumonia illness at presentation was
assessed using the British Thoracic Society's severity of
illness index CRB-65 [24]. The CRB-65 score ranges from
1 (not severe) to 4 (highly severe) for elderly population.
This is a more practical index for assessing severity of
pneumonia illness at presentation because it is easy and
quick to assess the severity, where blood urea measure-
ment is omitted from the CURB-65 scale [24]. Antibiotics
prescribed on admission were defined as "appropriate" if
they were respiratory fluroqualone alone or a combina-
tion of advance macrolide and beta-lactum antibiotics.Neupane et al. BMC Geriatrics 2010, 10:22
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This classification is based on Canadian guidelines for the
management of CAP in an in-patient setting [25].
Patients were followed up for 30 days from initial hospi-
talization for their mortality. The patients discharged
alive to home, nursing home or another hospital within
30 days of initial hospitalization were followed up to 90
days of initial hospitalization and their hospital re-admis-
sion was determined by telephone interview or review of
medical charts.
Statistical Analysis
For the statistical analysis, we defined the outcome "mor-
tality" event as any death that occurred within 30 days of
the initial hospital admission. We also did a sensitivity
analysis where we alternatively defined "mortality" out-
c o m e  a s  a n y  d e a t h s  w i t h i n  3 0  d a y s  c o m p a r e d  t o  d i s -
charges alive within 30 days, while excluding patients
who were still in the hospital more than 30 days after the
initial admission. "Re-hospitalization" was defined as hos-
pitalization for any reason within 90 days of the initial
hospitalization among those patients who were dis-
charged alive within 30 days of the initial hospitalization.
In the univariate analysis, we tested the crude associa-
tions of variables of interest using two-sided tests (Chi-
squared tests for binary variables and t-tests for continu-
ous variables) with the mortality and readmission out-
comes. Association was expressed as odds ratio (OR)
with corresponding 95% confidence interval (CI) for each
binary variable and as mean difference with correspond-
ing 95% CI for each continuous variable.
In the multivariable regression model, certain variables
of interest (i.e. lower socioeconomic status, appropriate
antibiotic prescription upon admission, influenza vacci-
nation, pneumococcal vaccination, lower nutritional risk
(i.e., higher nutrition score), and lower functional status)
were selected a priori for adjustment whereas the other
variables were considered as candidate variables for mul-
tivariable model of each outcome if they had p-value of ≤
.10 in the corresponding univariate analysis. We used
logistic regression with a step-wise backward elimination
approach to develop the final model for mortality and re-
hospitalization separately. Thus, the final model for each
outcome included the variables selected a priori and any
other variables that remained statistically significant (p <
0.05) in two-sided tests. Adjusted associations are
expressed as ORs and corresponding 95% CIs.
Data were analyzed using SAS for Windows version 9.1
(SAS Institute Inc. Cary, NC).
Results
There were 717 patients (365 from Hamilton and 352
from Edmonton) enrolled. Forty nine (6.8%) died within
30 days and 603 (84.1%) were alive at 30 days of hospital
admission of whom 526 (73.3%) were discharged alive
from the hospitals to their homes, nursing homes or
another hospitals and 77 (10.7%) were still in the same
hospitals for more than 30 days (see Figure 1). Fifty eight
(11.0%) of 526 patients discharged alive within 30 days of
initial hospitalization were re-admitted within 90 days of
initial hospitalization. Descriptive statistics by outcome
status and unadjusted associations of factors with mortal-
ity and re-hospitalization are presented in Table 1 and
Table 2, respectively. Adjusted associations with mortal-
ity and re-hospitalization are presented in Table 3 and 4,
respectively.
In the multivariable model, history of hip fracture (OR
= 4.00, 95% CI = (1.46, 10.96), P = .007), chronic obstruc-
tive pulmonary disease (OR = 2.31, 95% CI = (1.18, 4.50),
P = .014), and cerebrovascular disease (OR = 2.11, 95% CI
= (1.03, 4.31), P = .040) were significantly associated with
mortality (Table 3). In the sensitivity analysis that
excluded patients who remained in hospital for more
than 30 days, essentially the same results were found.
Only male sex (OR = 2.35, 95% CI = (1.13, 4.85), P =
.022) was significantly associated with re-hospitalization
while vitamin E supplementation was protective (OR =
0.37 (0.16, 0.90), P = .028) (Table 4).
Discussion
We found that in older adults hospitalized with pneumo-
nia, there was an increased risk of inhospital mortality
associated with hip fracture, chronic obstructive pulmo-
nary disease, and cerebrovascular disease. These findings
are consistent with previous reports [14,26-28]. Among
patients discharged from hospital within first 30 days,
being male was associated with hospital re-admission
within 90 days of initial hospitalization.
Taking vitamin E supplements was protective of re-hos-
pitalization in our study. Vitamin E inadequacy leads to
increased prostaglandin (PG)E2 production by alveolar
macrophages, a hypothesized mechanism through which
vitamin E deficiency may suppress T-cell-mediated
immunity [29]. However, the clinical effect on outcomes
is not well defined, with some studies showing benefit in
those with deficiencies and other studies showing no
benefit [30]. The fact however that these results are based
on self-reported use of Vitamin E is an important limita-
tion.
Lower educational level was not significantly associated
with re-hospitalization. This is in contrast to other
reports where lower education status and lack of employ-
m e n t  h a v e  b e e n  a s s o c i a t e d  w i t h  r e - h o s p i t a l i z a t i o n  i n
poor urban areas [30,31]. Given the risk of re-hospitaliza-
tion nearly twice as high in those with lower educational
status where p-value was close to .05 and many variables
were adjusted for sample size that was reduced for re-
hospitalization due missing values, it is possible that ourNeupane et al. BMC Geriatrics 2010, 10:22
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Page 4 of 10
Table 1: Descriptive statistics by mortality status and crude associations with mortality within 30 days of initial 
hospitalization for community acquired pneumonia.
Factorsa Mortality within 30 
days (n = 49)
Alive at 30 days 
(n = 603)
Mortality vs. alive at 30 days
OR (95% CI) P
Demographic factors
Age (years)b 79.3 (8.6) 79.1 (7.6) 0.26 (-1.98, 2.50) .819
Male Sex 31 (64.6) 365 (60.4) 1.19 (0.65, 2.21) .571
Married, living with 
spouse
29 (60.4) 310 (51.8) 1.42 (0.78, 2.58) .252
Living Alone 13 (26.5) 187 (32.6) 0.75 (0.39, 1.44) .384
BMIa 24.7 (4.7) 25.4 (5.9) -0.67 (-2.49, 1.15) .471
Low socioeconomic 
status
Education (< high 
school)
32 (65.3) 366 (61.5) 1.18 (0.64, 2.17) .599
Empiric Antibiotic 
Use
Appropriate 
Antibiotics
44 (89.8) 511 (83.9) 1.69 (0.65, 4.36) .275
Pneumonia Severity
CRB-65a 1.52 (0.7) 1.54 (0.7) -0.02 (-0.21, 0.17) .834
Immunization history
Influenza Vaccine 38 (77.6) 473 (79.0) 0.92 (0.46, 1.85) .816
Pneumococcal Vaccine 24 (49.0) 342 (57.8) 0.70 (0.39, 1.26) .232
Comorbidities
Asthma 13 (27.7) 142 (24.0) 1.21 (0.62, 2.35) .576
Cancer 11 (22.9) 156 (26.3) 0.83 (0.41, 1.67) .607
Cerebrovascular 
Diseasec
16 (33.3) 115 (19.3) 2.08 (1.11, 3.93) .021
Congestive Heart 
Failure
18 (39.1) 196 (33.5) 1.28 (0.69, 2.36) .438
COPDc 31 (66.0) 284 (48.0) 2.10 (1.13, 3.92) .018
Diabetes Mellitus 8 (16.7) 155 (26.0) 0.57 (0.26, 1.24) .152
Dysphagia 10 (20.8) 78 (13.2) 1.73 (0.83, 3.62) .138
Hip Fracturec 7 (14.6) 29 (4.9) 3.33 (1.38, 8.07) .005
Liver Diseasec, d 4 (8.7) 11 (1.9) 5.03 (1.54, 16.48) .003
Renal Disease 9 (20.0) 109 (18.6) 1.10 (0.51, 2.34) .812
Mineral supplement 
and medication 
history
Vitamin E 
Supplementation
9 (18.3) 134 (23.1) 0.75 (0.35, 1.58) .448
Zinc Supplementation 5 (10.2) 65 (11.4) 0.88 (0.34, 2.30) .796
Immunosuppressive 
Drugs
8 (18.2) 93 (16.4) 1.13 (0.51, 2.51) .760Neupane et al. BMC Geriatrics 2010, 10:22
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study did not have sufficient power to demonstrate such
an association.
Neither influenza nor pneumococcal vaccine appeared
to have any protective effect on mortality or re-hospital-
ization. In a study, Herzog et al. found influenza vaccina-
tion to be protective against mortality and readmission in
older adults hospitalized with pneumonia [8]. However,
there are conflicting reports for pneumococcal vaccina-
tion [9,10]. It should be noted, however, that one of the
concerns using observational designs to determine the
benefits associated with immunizations is that individu-
als who are healthier may be more likely to be immunized
and this could be the reason for observed protective
effects. Moreover, thelow rate of death at 30 days (6.8%)
may have limited our ability to detect a significant protec-
tive effect of pneumococcal vaccine.
We found no significant association between nutri-
tional status and mortality or re-hospitalization. In con-
trast, Vecchiarino et al. found a positive association of
death and re-hospitalization with malnutrition, assessed
on the basis of a low serum albumin or a reported unin-
tentional weight loss [15]. Requelme et al. also found a
significant association between nutrition and mortality
[16]. There are several possible explanations for these dif-
ferences. For example, we might not have sufficient mor-
tality and re-hospitalization cases to detect such
associations in this cohort study. In addition, our sample
was fairly homogeneous in terms of nutrition risk with
84.2% having higher one-third nutrition scores (scores
between 40 and 60). As a result, our measurement might
not have adequately discriminated high risk and low risk
patients in terms of mortality or re-hospitalization.
We also did not observe any association between func-
tional status and mortality or re-hospitalization. Vecchia-
rino et al. [15] and Cabre et al. [17], on the other hand,
found that poor functional status was associated with 30-
day mortality. However, the association with mortality
was not significant in Mody and Bradley study [18]. One
possible explanation is that the Barthel Index was insuffi-
ciently discriminatory in our population where most of
the patients had very high Barthel scores.
Previous data suggest that appropriate antibiotic pre-
scription prior to hospital admission is associated with
reduced mortality in patients with community-acquired
pneumonia [12,13]. However, we did not find such an
association. This may be because there were relatively
few inappropriate prescriptions (only 15.6% of all antibi-
otic prescriptions); so those who died were mostly from
initial antibiotic appropriately prescribed group. Also, we
might not expect an association between appropriate
antibiotic prescription and re-hospitalization because
impact of appropriate antibiotic prescription would have
attenuated prior to hospital discharge when patients' con-
ditions have stabilized (absence of fever and severe respi-
ratory distress). Therefore, complications during
hospitalization or new or coexisting medical illnesses
would have potentially greater impact on re-hospitaliza-
tion. Alternatively, there might be also significant varia-
tion in the effectiveness of different types and generations
of antibiotics that we termed 'appropriate' collectively,
especially among more severely ill patients who are more
likely to die or have more severe complications[31].
We found associations between traditional variables
and outcomes. But, none of the variables that we tested as
potentially modifiable variables appeared to be statisti-
cally significant. Strength of our multi-centered study is
that we considered pure pneumonia cases confirmed by
radiologists following strict selection criteria where all
exposure information was obtained prospectively. We
also adjusted many variables of interests or confounding
Lifestyle factors
Smoking (> 100 
cigarettes)
39 (79.6) 447 (74.3) 1.35 (0.66, 2.77) .409
Household Smoking 11 (22.5) 111 (18.4) 1.28 (0.63, 2.58) .489
Alcohol (gram/
month)a
16.1 (41.3) 10.6 (36.8) 5.46 (-5.48, 16.40) .328
Nutritional Scorea 45.3 (8.8) 47.0 (6.8) -1.70 (-3.76, 0.35) .198
Low functional status
Barthel Score (≤ 17) 12 (24.5) 142 (23.7) 1.04 (0.53, 2.06) .901
aDescriptive statistics are expressed as mean (standard deviation (SD)) for continuous variables and count (percentage) for binary variables
bContinuous variables
cp ≤ .10
dRare exposure (not considered as candidate variable for multivariable analysis for mortality even when it was statistically significant in 
univariate analysis).
Table 1: Descriptive statistics by mortality status and crude associations with mortality within 30 days of initial 
hospitalization for community acquired pneumonia. (Continued)Neupane et al. BMC Geriatrics 2010, 10:22
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Table 2: Descriptive statistics by re-hospitalization status and crude associations with re-hospitalization with 90 days of 
initial hospitalization for community acquired pneumonia.
Factorsa Re-hospitalization within 90 days of initial hospitalization
Yes
(n = 58)
No
(n = 261)
OR (95% CI) P
Demographic factors
Age (years)b 79.3 (7.1) 79.8 (7.8) -0.47 (-2.67, 1.72) .673
Male Sexc 44 (75.9) 150 (58.1) 2.26 (1.18, 4.34) .012
Married, living with 
spouse
33 (58.9) 131 (50.4) 1.41 (0.79, 2.54) .246
Living Alone 13 (23.2) 84 (34.2) 0.58 (0.30, 1.14) .114
BMIa 25.5 (6.0) 25.3 (5.6) 0.21 (-1.49, 1.91) .810
Low socioeconomic 
status
Education (< high 
school)c
45 (79.0) 158 (62.0) 2.30 (1.16, 4.57) .015
Empiric Antibiotics 
Use
Appropriate 
Antibiotics
50 (86.2) 216 (82.8) 1.30 (0.58, 2.93) .523
Pneumonia Severity
CRB-65a 1.5 (0.6) 1.56 (0.7) -0.06 (-0.25, 0.13) .555
Immunization history
Influenza Vaccination 48 (82.8) 198 (78.0) 1.36 (0.65, 2.85) .419
Pneumococcal 
Vaccination
33 (58.9) 142 (55.3) 1.16 (0.64, 2.09) .616
Comorbidities
Asthma 14 (25.5) 62 (24.5) 1.05 (0.54, 2.06) .882
Cancer 17 (32.1) 66 (26.0) 1.35 (0.71, 2.55) 364
Cerebrovascular 
Disease
15 (26.8) 56 (21.9) 1.31 (0.67, 2.53) 427
Congestive Heart 
Failure
24 (43.6) 95 (37.9) 1.27 (0.70, 2.30) 425
COPD 32 (58.2) 131 (51.2) 1.33 (0.74, 2.39) 345
Diabetes Mellitus 14 (25.0) 66 (25.5) 0.97 (0.50, 1.90) 940
Dysphagia 10 (17.9) 38 (14.9) 1.24 (0.58, 2.67) 579
Hip Fracture 2 (3.58) 11 (4.28) 0.83 (0.18, 3.84) 810
Liver Disease 1 (1.8) 2 (0.8) 2.3 (0.20, 25.82) 488
Renal Disease 13 (23.2) 40 (15.8) 1.61 (0.79, 3.26) 184
Mineral supplement 
and medication 
history
Vitamin E 
Supplementationc
8 (15.1) 73 (28.9) 0.44 (0.20, 0.97) 039
Zinc Supplementation 5 (9.6) 33 (13.4) 0.69 (0.26, 1.86) 461
Immunosuppressive 
Drugs
14 (25.0) 40 (16.1) 1.73 (0.87, 3.47) 117Neupane et al. BMC Geriatrics 2010, 10:22
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variables in order to minimize bias in the results. How-
ever, this was also the limitation of the study in terms of
statistical power of the study because we had only few
mortality and re-hospitalization events and the variables
we assessed as potentially modifiable factors for mortality
or re-hospitalization were either very common or very
rare exposures in our cohort. Also, the effective sample
size used for re-hospitalization was very small and as a
consequence factors such as socio-economic status were
not statistically significant even when the estimate of
association was quite large. This is because we could not
confirm re-hospitalization status for many participants
who might either have moved out from their residential
address or could not be contacted for other reasons.
Since we were interested only on the factors at baseline or
at the time of hospitalization, we did not consider and
Lifestyle factors
Smoking (> 100 
cigarettes)
44 (77.2) 201 (77.3) 0.99 (0.50, 1.97) 985
Household Smoking 12 (21.1) 47 (18.1) 1.21 (0.59, 2.46) 601
Alcohol (gram/
month)a, c
5.8 (15.8) 10.6 (31.6) -4.86 (-13.33, 3.61) 093
Nutritional Scorea 48.7 (5.9) 47.3 (6.7) 1.41 (-0.49, 3.31) 145
Low functional status
Barthel Score (≤ 17) 9 (15.8) 60 (23.2) 0.62 (0.29, 1.34) 222
aDescriptive statistics are expressed as mean (standard deviation (SD)) for continuous variables and count (percentage) for binary variables
bContinuous variables
cp ≤ .10
Table 2: Descriptive statistics by re-hospitalization status and crude associations with re-hospitalization with 90 days of 
initial hospitalization for community acquired pneumonia. (Continued)
Table 3: Adjusted associations with mortality within 30 days of initial hospitalization for community acquired pneumonia.
Factors Mortalitya Mortalityb
OR (95% CI) P OR (95% CI) P
Lower socioeconomic 
status (Education < 
high school)
0.99 (0.51, 1.92) 983 0.98 (0.50, 1.91) 953
Influenza vaccination 1.36 (0.57, 3.21) 488 1.21 (0.51, 2.89) 660
Pneumococcal 
vaccination
0.64 (0.32, 1.27) 203 0.66 (0.33, 1.32) 243
Appropriate antibiotic 
use
1.71 (0.65, 4.52) 281 1.84 (0.69, 4.91) 220
Nutrition score 0.85 (0.68, 1.06)c 145 0.85 (0.68, 1.06)c 142
Lower functional 
status (Barthel 
score ≤ 17)
0.72 (0.33, 1.60) 423 0.70 (0.31, 1.56) 381
Hip Fracture 4.00 (1.46, 10.96) 007 4.27 (1.50, 12.18) 007
COPD 2.31 (1.18, 4.50) 014 2.25 (1.15, 4.39) 018
Cerebrovascular 
disease
2.11 (1.03, 4.31) 040 2.30 (1.11, 4.76) 025
aMortality within 30 days vs. alive at 30 days of hospital admission
bMortality within 30 days vs. discharged alive within 30 days of hospital admission (excluding those who remained in the hospitals for more 
than 30 days)
cOdds ratio for 5 points increment in scoreNeupane et al. BMC Geriatrics 2010, 10:22
http://www.biomedcentral.com/1471-2318/10/22
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adjust any independent predictor of outcomes during
hospitalization such as any superinfection e.g., diarrhea;
or any other new and serious complications e.g., respira-
tory failure; or receiving extra medical attention, e.g., ICU
admission; or drug related adverse events, e.g., adverse
reaction. Some of these conditions might have affected
the outcomes [32-34] and are also related to other vari-
ables introducing confounding bias as happens in obser-
vational studies.
Conclusion
Chronic comorbidities appear to be the most important
predictors of death and re-hospitalization in older adults
hospitalized with community-acquired pneumonia. Vita-
min E supplementation also appeared to be protective
from (re)hospitalization for any disease following dis-
charge from hospitals for pneumonia infection. Other
variables that we tested as potentially modifiable to the
Table 4: Adjusted association with re-hospitalization within 90 days of initial hospitalization for CAP.
Factors OR (95% CI) P
Lower socioeconomic status (Education < 
high school)
1.98 (0.95, 4.13) 069
Influenza vaccination 0.92 (0.39, 2.18) 842
Pneumococcal vaccination 1.45 (0.70, 3.02) 319
Appropriate antibiotic use 1.44 (0.58, 3.57) 428
Nutrition score 1.17 (0.89, 1.54)a 254
Lower functional status (Barthel 
score ≤ 17)
0.70 (0.31, 1.61) 406
Male Sex 2.35 (1.13, 4.85) 022
Vitamin E supplement 0.37 (0.16, 0.90) 028
OR = Odds ratio; CI = Confidence interval
aOdds ratio for 5 points increment
Figure 1 Mortality and re-hospitalization in the cohort of patients hospitalized for community-acquired pneumonia.
Initial enrollment 
(Mortality cohort)       
n = 717 
Mortality within 30 days     
n = 49 (6.8%) 
Alive at 30 days   
n = 603 (84.1%) 
Still in the hospital for 
more than 30 days        
n = 77 (10.7%)
Missing           
n = 65 (9.1%) 
Missing             
n = 207 (39.4%) 
No re-hospitalization      
n = 261 (49.6%) 
Re-hospitalization within 90 days       
n = 58 (11.0%) 
Discharged and alive within 30 days 
(Re-hospitalization cohort)             
n = 526 (73.4%)
Discharged, re-hosp-
italized and died         
n = 1 (0.1%)
Died in the 
hospitals         
n = 48 (6.7%)Neupane et al. BMC Geriatrics 2010, 10:22
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in-hospital mortality and rehospitalization did not appear
to have any associations.
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